Value of information methods to design a clinical trial in a small population to optimise a health economic utility function
暂无分享,去创建一个
Martin Posch | Sarah Zohar | Siew Wan Hee | Jason Madan | Nigel Stallard | Simon Day | Frank Miller | J. Madan | M. Posch | S. Hee | N. Stallard | S. Day | F. Miller | S. Zohar | Michael Pearce | Michael Pearce
[1] John Gittins,et al. A Behavioral Bayes Method for Determining the Size of a Clinical Trial , 2000 .
[2] D. Berry,et al. Choosing sample size for a clinical trial using decision analysis , 2003 .
[3] Cyrus R Mehta,et al. Adaptive, group sequential and decision theoretic approaches to sample size determination , 2006, Statistics in medicine.
[4] Hamid Pezeshk,et al. A Fully Bayesian Approach to Calculating Sample Sizes for Clinical Trials with Binary Responses , 2002 .
[5] A. Willan,et al. Value of Information and Pricing New Healthcare Interventions , 2012, PharmacoEconomics.
[6] D. Dixon. Bayesian methods and ethics in a clinical trial design , 1997 .
[7] J. Kadane,et al. Experiences in elicitation , 1998 .
[8] C. Chiaverini,et al. Prevalence of inherited ichthyosis in France: a study using capture-recapture method , 2014, Orphanet Journal of Rare Diseases.
[9] J. Gittins,et al. A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety , 2009, Statistics in medicine.
[10] P. Marriott,et al. An Optimization Approach to Calculating Sample Sizes With Binary Responses , 2014, Journal of biopharmaceutical statistics.
[11] J. Madan,et al. Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov , 2017, Orphanet Journal of Rare Diseases.
[12] Lisa V Hampson,et al. Bayesian methods for the design and interpretation of clinical trials in very rare diseases , 2014, Statistics in medicine.
[13] Andrew R Willan,et al. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods , 2013, Clinical trials.
[14] Andrew R Willan,et al. Expected value of information and decision making in HTA. , 2007, Health economics.
[15] A E Ades,et al. Expected Value of Sample Information Calculations in Medical Decision Modeling , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] Hamid. Pezeshk,et al. How large should a clinical trial be , 2000 .
[17] Nitin R Patel,et al. A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs , 2007, Statistics in medicine.
[18] Anthony O'Hagan,et al. Eliciting expert beliefs in substantial practical applications , 1998 .
[19] C. Tudur Smith,et al. A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov , 2014, Orphanet Journal of Rare Diseases.
[20] J. Beyene,et al. Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A , 2013, Journal of General Internal Medicine.
[21] J Hornberger,et al. The cost-benefit of a randomized trial to a health care organization. , 1998, Controlled clinical trials.
[22] B W Brown,et al. The sample size for a clinical trial: A Bayesian–decision theoretic approach , 2001, Statistics in medicine.
[23] B. Buckley. Clinical trials of orphan medicines , 2008, The Lancet.
[24] Thomas A. Louis,et al. Graphical Elicitation of a Prior Distribution for a Clinical Trial , 1993 .
[25] Donald A. Berry,et al. Group sequential clinical trials: a classical evaluation of Bayesian decision-theoretic designs , 1994 .
[26] Andrew R Willan,et al. The value of information and optimal clinical trial design , 2005, Statistics in medicine.
[27] J. Gittins,et al. The choice of sample size: a mixed Bayesian / frequentist approach , 2009, Statistical methods in medical research.
[28] Vahid Montazerhodjat,et al. Is the Fda Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design , 2015, Journal of Econometrics.
[29] Martin Posch,et al. Decision-theoretic designs for small trials and pilot studies: A review , 2015, Statistical methods in medical research.
[30] Haolun Shi,et al. Bayesian randomized clinical trials: From fixed to adaptive design. , 2017, Contemporary clinical trials.
[31] D A Berry,et al. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. , 1988, Biometrics.
[32] Andrew R Willan,et al. Optimal sample size determinations from an industry perspective based on the expected value of information , 2008, Clinical trials.
[33] Simon Day,et al. Structured approach to the elicitation of expert beliefs for a Bayesian‐designed clinical trial: a case study , 2013, Pharmaceutical statistics.
[34] Martin Posch,et al. Determination of the optimal sample size for a clinical trial accounting for the population size , 2016, Biometrical journal. Biometrische Zeitschrift.